We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+33.33%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.76B
AUM Growth
+$349M
Cap. Flow
+$63.3M
Cap. Flow %
3.6%
Top 10 Hldgs %
46.56%
Holding
242
New
48
Increased
31
Reduced
35
Closed
71

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$45.5M
2
RDUS
Radius Health, Inc.
RDUS
+$27.1M
3
EVH icon
Evolent Health
EVH
+$21.8M
4
LJPC
La Jolla Pharmaceutical Company
LJPC
+$20.9M
5
ANAB icon
AnaptysBio
ANAB
+$20.5M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$72.8M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$39.5M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$30.9M
4
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
+$23.3M
5
ACOR
Acorda Therapeutics
ACOR
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 98.25%
2 Miscellaneous 1.35%
3 Consumer Staples 0.26%
4 Consumer Discretionary 0.06%
5 Industrials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
201
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-498,198
Closed -$39.5M
TCON
202
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
– –
-500
Closed -$448K
ALPN
203
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-30,569
Closed -$274K
AVGR
204
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– -$4K
MRTX
205
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-521
Closed -$2K
SYNH
206
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-12,636
Closed -$665K
ISEE
207
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-220,400
Closed -$5K
ISEE
208
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-1,600
Closed -$24K
ACOR
209
DELISTED
Acorda Therapeutics
ACOR
– –
-6,000
Closed -$13.5M
AGRX
210
DELISTED
Agile Therapeutics
AGRX
– –
-331
Closed -$1.66M
ALR
211
DELISTED
AlerisLife Inc
ALR
– –
-6,780
Closed -$183K
MYOV
212
DELISTED
Myovant Sciences Ltd.
MYOV
– –
-226,322
Closed -$2.81M
AGTC
213
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-50,251
Closed -$470K
ENDP
214
DELISTED
Endo International plc
ENDP
– –
-12,920
Closed -$213K
MGLN
215
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-7,508
Closed -$565K
NEOS
216
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-1,056
Closed -$6K
STML
217
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-10,702
Closed -$115K
MDCO
218
PUT
DELISTED
Medicines Co
MDCO
– –
-200,000
Closed -$1.07M
ESRX
219
DELISTED
Express Scripts Holding Company
ESRX
– –
-6,639
Closed -$457K
IPXL
220
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-1
Closed –
SCMP
221
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
– –
-30,694
Closed -$416K
PZRX
222
DELISTED
PhaseRx, Inc.
PZRX
– –
-200,000
Closed -$310K
CEMP
223
DELISTED
Cempra, Inc.
CEMP
– –
-22,321
Closed -$62K
MACK
224
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-6,216
Closed -$200K
INNL
225
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
– –
-9,433
Closed -$7K
6 7 8
9
10

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Perceptive Advisors held 242 positions worth $1.76B, up 25% from $1.41B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Perceptive Advisors deployed $63.3M of net new capital in Q1 2017, opening 48 new positions and adding to 31 existing holdings. Its largest new stake was AnaptysBio: 881,957 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was TESARO, Inc., an estimated $72.8M trimmed.

  • Perceptive Advisors's largest Q1 2017 buy was AnaptysBio: 881,957 shares worth $24.5M.
  • Perceptive Advisors added most to Alnylam Pharmaceuticals in Q1 2017, an estimated $45.5M increase.
  • Perceptive Advisors's biggest Q1 2017 reduction was TESARO, Inc., cutting an estimated $72.8M.
  • Perceptive Advisors fully exited Eagle Pharmaceuticals, Inc. in Q1 2017, selling an estimated $39.5M.
  • Perceptive Advisors's ten largest holdings make up 47% of its $1.76B portfolio in Q1 2017.
  • Perceptive Advisors opened 48 new positions and closed 71 in Q1 2017.
  • Perceptive Advisors's portfolio value rose 25% quarter-over-quarter to $1.76B.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.